Scalar

Scalar Bioscience is a biotechnology and medical technology company dedicated to developing innovative products that improve patient quality of life and healthcare delivery efficiency. Originally founded as Sensory Arts & Science, the company rebranded in 2016 to reflect its expanded focus on both diagnostics and therapeutics, particularly in the fields of vision and hearing care. Its lead commercialized efforts include the MacViewer for early detection of age-related macular degeneration and the RemotEAR tele-audiology platform. The company operates an innovation-to-commercialization business model, where it develops proof-of-concept technologies and then either licenses them to partners or launches dedicated subsidiaries, such as the upcoming Terra Therapeutics.